Journal of experimental & clinical cancer research, 2020-01, Vol.39 (1), p.10-10, Article 10
2020
Details
- Autor(en) / Beteiligte
- Titel
- Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
- Ist Teil von
- Journal of experimental & clinical cancer research, 2020-01, Vol.39 (1), p.10-10, Article 10
- Ort / Verlag
- England: BioMed Central Ltd
- Erscheinungsjahr
- 2020
- Link zum Volltext
- Quelle
- EZB Electronic Journals Library
- Beschreibungen/Notizen
- In the original publication of this article [1], labelling within Fig. 7a was incorrect. The updated figure is shown below, with 'DMT1' now corrected to read 'DNMT1'.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1756-9966, 0392-9078eISSN: 1756-9966DOI: 10.1186/s13046-019-1518-zTitel-ID: cdi_doaj_primary_oai_doaj_org_article_cc590f14bbba44d28494b50c05fb1542
- Format
- –
- Schlagworte
- Antineoplastic agents, Cancer, Carcinoma, Hepatocellular carcinoma, Labels, Medical colleges, Medical schools, Medicine, Methyltransferases, Prognosis, Sorafenib